Multi_CycGT: a DL-based multimodal model for membrane permeability prediction of cyclic peptides

As a highly versatile therapeutic modality, cyclic peptides have gained significant attention due to their exceptional binding affinity, minimal toxicity and capacity to target the surface of conventionally “undruggable” proteins. However, the development of cyclic peptides with therapeutic effects by targeting intracellular biological targets has been hindered by the issue of limited membrane permeability. In this paper, we have conducted an extensive benchmarking analysis of a proprietary dataset consisting of 6941 cyclic peptides, employing machine learning and deep learning models. In addition, we propose an innovative multimodal model called Multi_CycGT which combines a Graph Convolutional Network (GCN) and a Transformer to extract 1D and 2D features. These encoded features are then fused for the prediction of cyclic peptide permeability. The cross-validation experiments demonstrate that the proposed Multi_CycGT model achieved the highest level of accuracy on the test set, with an accuracy value of 0.8206 and an AUC value of 0.8650. This paper introduces a pioneering deep learning-based approach that demonstrates enhanced effectiveness in predicting the membrane permeability of cyclic peptides. It also represents the first attempt in this field. We hope that this work will help to accelerate the design of cyclic peptide active drugs in medicinal chemistry and chemical biology applications.

[1]  Y. Akiyama,et al.  CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides , 2023, J. Chem. Inf. Model..

[2]  Matthew R. Naylor,et al.  Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides , 2023, Nature Communications.

[3]  T. Le,et al.  Membrane Permeating Macrocycles: Design Guidelines from Machine Learning , 2022, J. Chem. Inf. Model..

[4]  Shiyu Chen,et al.  Cyclic peptide drugs approved in the last two decades (2001–2021) , 2021, RSC chemical biology.

[5]  G. Caron,et al.  Permeability prediction in the beyond-Rule-of 5 chemical space: focus on cyclic hexapeptides. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Zewen Li,et al.  A Survey of Convolutional Neural Networks: Analysis, Applications, and Prospects , 2020, IEEE Transactions on Neural Networks and Learning Systems.

[7]  Xuechen Li,et al.  Ligation Technologies for the Synthesis of Cyclic Peptides. , 2019, Chemical reviews.

[8]  Yang Jiang,et al.  Macrocyclic peptides as regulators of protein-protein interactions , 2018, Chinese Chemical Letters.

[9]  Jolene L. Lau,et al.  Therapeutic peptides: Historical perspectives, current development trends, and future directions. , 2017, Bioorganic & medicinal chemistry.

[10]  Lukasz Kaiser,et al.  Attention is All you Need , 2017, NIPS.

[11]  Ulf Norinder,et al.  Structural and conformational determinants of macrocycle cell permeability. , 2016, Nature chemical biology.

[12]  Max Welling,et al.  Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.

[13]  Alun Jones,et al.  Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides , 2015, Chembiochem : a European journal of chemical biology.

[14]  D. Murray,et al.  Romidepsin targets multiple survival signaling pathways in malignant T cells , 2015, Blood Cancer Journal.

[15]  Matthew P. Jacobson,et al.  Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products. , 2015, Future medicinal chemistry.

[16]  Spiros Liras,et al.  Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability. , 2015, European journal of medicinal chemistry.

[17]  Yizhong Zhang,et al.  Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance(). , 2012, MedChemComm.

[18]  Cristiano Ruch Werneck Guimarães,et al.  Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation , 2012, J. Chem. Inf. Model..

[19]  D. Craik,et al.  Discovery and applications of naturally occurring cyclic peptides. , 2012, Drug discovery today. Technologies.

[20]  Christopher J. White,et al.  Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.

[21]  H. Kessler,et al.  N‐Methylation of Peptides: A New Perspective in Medicinal Chemistry , 2009 .

[22]  Stephen P. Hale,et al.  The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.

[23]  Horst Kessler,et al.  Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. , 2008, Angewandte Chemie.

[24]  Matthew P Jacobson,et al.  Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.

[25]  C. Lipinski Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[26]  Yoshua Bengio,et al.  Convolutional networks for images, speech, and time series , 1998 .

[27]  S. Hochreiter,et al.  Long Short-Term Memory , 1997, Neural Computation.

[28]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[29]  T. Hoffmann,et al.  Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.

[30]  Peter E. Hart,et al.  Nearest neighbor pattern classification , 1967, IEEE Trans. Inf. Theory.